Catheter Precision to present FDA-cleared, non-invasive 3D VIVO technology at cardiac robotic navigation meeting in Lisbon.

Catheter Precision, a U.S. medical device company, will present its VIVO technology at the International Society for Cardiac Robotic Navigation Meeting in Lisbon on October 28-29. VIVO is a non-invasive 3D imaging system for identifying ventricular arrhythmias prior to procedures and aims to enhance workflow and reduce procedure time. The technology has FDA clearance and a CE mark. Presentations will include updates on clinical data and the European Registry.

October 23, 2024
4 Articles

Further Reading